MS and MOGAD share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study ...
Maybe healing after an MS relapse isn't in striving to feel better, but is found in savoring where you are now, writes ...
Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...
As Thanksgiving approaches, columnist Leigh Anne Nelson is focused on what gratitude really means and appreciating the small ...
Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.
Two Phase 3 trials testing the investigational oral therapy fenebrutinib in people with multiple sclerosis (MS) have hit ...
The ComSLI method uses simple tools to generate detailed images of brain nerve fibers and damage in neurological diseases, ...
A wearable system that measures the brain's electrical activity can show how brain circuits are affected in people with MS, a ...
Columnist Ben Hofmeister sings the praises of his wife and caregiver, who knows that living with MS is like speaking a foreign language.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results